Description

Plamumab 40 mg Injection contains Adalimumab, a monoclonal antibody biosimilar used in specialist-managed immunology and autoimmune care. It is provided in a pre-filled syringe format to ensure accurate, controlled administration in clinical settings.

As a prescription biologic, Plamumab requires a thorough medical evaluation and ongoing monitoring by a licensed healthcare practitioner. Proper storage conditions—especially temperature control—are essential to maintain the medicine’s stability and effectiveness. The injection should only be administered by trained healthcare providers or under their guidance.

Important Note:
Plamumab 40 mg should not be self-used unless specifically trained and approved by a medical professional. Only a registered doctor can determine the appropriate dosage, schedule, and suitability. Follow all medical and regulatory guidelines when purchasing or handling prescription biologic injections.